Patricia C. Valery

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (14)

Jennifer H. Martin

AUSTRALIA

View details

Elizabeth Powell

University of Queensland

AUSTRALIA

View details

Michelle Allen

Queensland University of Technology

AUSTRALIA

View details

Amany Zekry

AUSTRALIA

View details

Anthony Russell

A.Professor of Medicine

University of Queensland

AUSTRALIA

View details

Simone Strasser

Head of Department

AUSTRALIA

View details

David Brain

Queensland University of Technology

AUSTRALIA

View details

James Ward

Professor

University of Queensland

AUSTRALIA

View details

Katharine M. Irvine

University of Queensland

AUSTRALIA

View details

James O'Beirne

University of the Sunshine Coast

AUSTRALIA

View details

Sanjeewa Kularatna

Queensland University of Technology

AUSTRALIA

View details

Gunter Hartel

Griffith University

AUSTRALIA

View details

Neil Cottrell

University of Queensland

AUSTRALIA

View details

Louisa Gordon

Queensland University of Technology

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Patricia C. Valery

Research Interests

Explore related searches

Contact this professor

Articles (23)

Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD trial)

Surviving Hepatitis C—Understanding Death and Survival Beyond Cure

Cause‐specific mortality among Queensland people with cirrhosis, by cirrhosis aetiology and decompensation status, 2007–22: a retrospective cohort study

Factors to Consider in the Selection of Noninvasive Fibrosis Tests for Metabolic Dysfunction–Associated Steatotic Liver Disease

High Fibrosis-4 is Associated With Increased Risk of Cirrhosis Decompensation and Liver-Related Mortality in at-Risk Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease

Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA‐C)

An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and Considerations

Australians with metabolic dysfunction‐associated steatotic liver disease have a twofold increase in the incidence of cancer

Rising hospital admissions for alcohol-related cirrhosis and the impact of sex and comorbidity – a data linkage study

High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia

Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care

Low Prevalence of Use of Allied Health and Community Services for Patients with Cirrhosis in Australia: A Need for Greater Engagement

Partnering with support persons and clinicians to improve the health care experiences of patients with cirrhosis

Improving primary care referral to specialist services: a protocol for a 10-year global systematic review in the Australian context

Higher levels of supportive care needs are linked to higher health service use and cost, poor quality of life, and high distress in patients with cirrhosis in Queensland, Australia

Diabetes mellitus and the progression of non‐alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study

An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care

Differences in the pattern and cost of hospital care between Indigenous and non-Indigenous Australians with cirrhosis: an exploratory study

Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up

Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort.

Low accuracy of FIB-4 test to identify people with diabetes at low risk of advanced fibrosis

Patient-oriented medication education intervention has long-term benefits for people with decompensated cirrhosis

Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory study

Collaborators (14)

Jennifer H. Martin

Elizabeth Powell

Michelle Allen

Amany Zekry

Anthony Russell

Simone Strasser

David Brain

James Ward

Katharine M. Irvine

James O'Beirne

Sanjeewa Kularatna

Gunter Hartel

Neil Cottrell

Louisa Gordon

Make your next move.